Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Cystic Fibrosis

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JCF.2004.03.005PMID 15463894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009cited by this paper
• Synthetic chloride channel restores glutathione secretion in cystic fibrosis airway epithelia.

  2001cited by this paper
• Glutathione in induced sputum of healthy individuals and patients with asthma

  2001influential reference
• Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group

  2000cited by this paper
• Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches.

  2000cited by this paper
• Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.

  2000cited by this paper
• Erratum: Abnormal glutathione transport in cystic fibrosis airway epithelia (American Journal of Physiology-Lung Cellular and Molecular Physiology (July 1999) 21, 277 (L113-L118))

  2000cited by this paper
• Abnormal glutathione transport in cystic fibrosis airway epithelia.

  1999cited by this paper
• Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients.

  1999cited by this paper
• Glutathione permeability of CFTR.

  1998cited by this paper
• Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis.

  1998cited by this paper
• Pulmonary oxidative stress response in young children with cystic fibrosis.

  1997cited by this paper
• Lower airway inflammation in infants and young children with cystic fibrosis.

  1997cited by this paper
• Rapid and Specific Efflux of Reduced Glutathione during Apoptosis Induced by Anti-Fas/APO-1 Antibody*

  1996cited by this paper
• Cystic fibrosis.

  1996cited by this paper
• Non-oxidative loss of glutathione in apoptosis via GSH extrusion.

  1995cited by this paper
• Early pulmonary inflammation in infants with cystic fibrosis.

  1995cited by this paper
• The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis

  1995cited by this paper
• Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.

  1994cited by this paper
• Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

  1994cited by this paper
• Systemic deficiency of glutathione in cystic fibrosis.

  1993cited by this paper
• Guidelines For The Diagnosis And Management Of Asthma

  1992cited by this paper
• The Lung: Scientific Foundations

  1991cited by this paper
• Normal alveolar epithelial lining fluid contains high levels of glutathione.

  1987cited by this paper
• Assays of glutathione peroxidase.

  1984cited by this paper
• Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples.

  1981cited by this paper

• Analysis of genetic requirements and nutrient availability for Staphylococcus aureus growth in cystic fibrosis sputum

  2025cites this paper
• Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application

  2025influential citation
• Modulating the Mucosal Drug Delivery Efficiency of Polymeric Nanogels Tuning their Redox Response and Surface Charge

  2024cites this paper
• Analysis of genetic requirements and nutrient availability for Staphylococcus aureus growth in cystic fibrosis sputum

  2024influential citation
• Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases

  2023cites this paper
• Hydrogen inhalation attenuated bleomycin‐induced pulmonary fibrosis by inhibiting transforming growth factor‐β1 and relevant oxidative stress and epithelial‐to‐mesenchymal transition

  2019cites this paper
• Low concentrations of clarithromycin upregulate cellular antioxidant enzymes and phosphorylation of extracellular signal-regulated kinase in human small airway epithelial cells

  2018cites this paper
• Can saliva testing replace blood measurements for health monitoring? Insights from a correlation study of salivary and whole blood glutathione in humans.

  2016cites this paper
• Oxidative Stress Markers in Sputum

  2016cites this paper
• Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis

  2016cites this paper
• Reply: glutathione inhalation treatments in cystic fibrosis: the interference of airway γ-glutamyltransferase.

  2014cites this paper
• The human CFTR protein expressed in CHO cells activates aquaporin-3 in a cAMP-dependent pathway: study by digital holographic microscopy

  2014cites this paper
• Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.

  2014cites this paper
• Introduction to Oxidative Stress and Antioxidant Therapy in Respiratory Disorder

  2014cites this paper
• Current concepts: host–pathogen interactions in cystic fibrosis airways disease

  2014cites this paper
• Der Einfluss einer inhalativen Glutathiontherapie auf die Inflammation bei Patienten mit zystischer Fibrose

  2013cites this paper
• The role of redox balance in pulmonary innate immunity

  2013cites this paper
• Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial.

  2013cites this paper
• Oxidative stress and antioxidant therapy in cystic fibrosis.

  2012cites this paper
• Down-regulation of Cytokine-induced Interleukin-8 Requires Inhibition of p38 Mitogen-activated Protein Kinase (MAPK) via MAPK Phosphatase 1-dependent and -independent Mechanisms*

  2011cites this paper
• High-Dose Ibuprofen in Cystic Fibrosis

  2010cites this paper
• Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11a

  2010cites this paper
• A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non-cystic fibrosis-like phenotype.

  2009cites this paper
• intestinal obstructions in cystic fibrosis mice Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of

  2009cites this paper
• Epithelial ion transport and gastrointestinal fluid homeostasis

  2009cites this paper
• Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.

  2009cites this paper
• Oxidative stress in the pathogenesis of diffuse lung diseases: a review.

  2009cites this paper
• Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice.

  2009cites this paper
• A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis

  2009cites this paper
• Reactions of Pseudomonas aeruginosa pyocyanin with reduced glutathione.

  2008cites this paper
• A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

  2007cites this paper
• Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid

  2006cites this paper
• Oxidant and antioxidant balance in the airways and airway diseases.

  2006cites this paper
• Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.

  2005cites this paper
• Antioxidant properties of cystic fibrosis sputum.

  2005cites this paper